Yi Qingqing 4
4 · BeiGene, Ltd. · Filed May 23, 2025
Insider Transaction Report
Form 4
BeiGene, Ltd.BGNE
Yi Qingqing
Director
Transactions
- Award
Ordinary Shares
2025-05-21+10,985→ 56,940 total - Award
Share Option (Right to Buy)
2025-05-21+22,750→ 22,750 totalExercise: $18.19Exp: 2035-05-20→ Ordinary Shares (22,750 underlying)
Footnotes (3)
- [F1]Represents securities underlying restricted share units ("RSUs"). All RSUs will vest upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.
- [F2]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares.
- [F3]The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.